Challenges to the Star Rating Methodology<\/strong><\/p>\r\n\r\n\r\n\r\nHumana and Blue Cross Blue Shield of Louisiana have also brought legal challenges against CMS, citing issues with the cut points that determine ratings. These insurers claim that changing cut points each year creates unpredictability, making it difficult for insurers to consistently achieve high ratings. They argue that CMS\u2019s adjustments to cut points lack transparency, complicating their ability to accurately assess and plan for quality improvements.<\/p>\r\n\r\n\r\n\r\n
Centene and UnitedHealthcare\u2019s Secret Shopper Complaints<\/h2>\r\n\r\n\r\n\r\n
\u00a0Disputes Over Secret Shopper Calls<\/strong><\/p>\r\n\r\n\r\n\r\nCentene and UnitedHealthcare, two other major players in the Medicare Advantage market, have taken issue with CMS\u2019s inclusion of \u201csecret shopper\u201d phone calls as a factor in determining star ratings. Both insurers allege that some of these calls were not properly connected to their call centers, leading to inaccurate evaluations. They argue that CMS\u2019s reliance on unverified call data unfairly impacts their ratings, further questioning the fairness of the rating system.<\/p>\r\n\r\n\r\n\r\n
2025 Star Rating Changes and Increased Cut Points<\/h2>\r\n\r\n\r\n\r\n
Higher Cut Points for 2025 and Industry Impact<\/strong><\/p>\r\n\r\n\r\n\r\nFor the 2025 plan year, CMS has increased the cut points, or thresholds, that determine star ratings for various performance metrics. This change has resulted in a decline in the average star rating, which dropped from 4.07 in 2024 to 3.92 in 2025. The shift means that insurers must now perform at a higher level to meet the same star rating standards as before, putting added pressure on plans to improve their quality scores.<\/p>\r\n\r\n\r\n\r\n
Conclusion<\/h2>\r\n\r\n\r\n\r\n
Elevance Health\u2019s lawsuit against CMS highlights ongoing concerns within the insurance industry about the accuracy, fairness, and transparency of the Medicare Advantage star rating system. As more insurers challenge CMS in court, the agency faces growing pressure to review and potentially revise its methodologies to address these concerns. The outcomes of these cases could have a significant impact on the future of Medicare Advantage ratings, quality bonuses, and the overall approach to evaluating plan performance.<\/p>\r\n\r\n\r\n\r\n
Discover the latest